Gary Clark: Unfiltered

A craft tequila partners with the Cubs, but this is more than a new ballpark drink. It’s a calculated signal of where sports marketing and consumer tastes are headed.

As firms flee global supply chain chaos, one Wisconsin manufacturer's bet on trust and proximity reveals the blueprint for America's industrial renewal.

In Malta, a partnership between Acronis and Eyetech is teaching kids cyber safety. It's more than a charity event; it's a blueprint for the future of CSR.

Amid new Ebola fears, one biotech's rapid C1 platform promises 15-day biologics, eyeing a $25B market beyond just pandemic response. But can it deliver?

As Germany's strict new cybersecurity law reshapes its telecom market, Mavenir's early certification gives it a key advantage in the post-Huawei era.

EVA Air President Clay Sun's historic election to the IATA board is more than a corporate win. It's a geopolitical masterstroke and a new chapter for global aviation.

A new book signals a major shift in the veterinary industry, where AI-driven strategy is becoming the key to survival and growth in a competitive market.

As Madonna and Absolut partner for 'Confessions II,' we unpack the financial and cultural mechanics of a deal built on shared history and experiential marketing.

The Chinese insurtech's massive share consolidation is a desperate bid to stay on Nasdaq, but it reveals deeper struggles facing Chinese ADRs in the US.

Takis' global partnership with 'Spider-Man: Brand New Day' is more than a snack tie-in; it's a blueprint for modern franchise marketing. Here's why.

Small businesses are under siege from cyberattacks. Comcast's new network-level security aims to be the answer, but is it a true shield or a strategic play?

MeasureUp's recent award for its iTalentUp platform isn't just a win; it's a signal flare for a revolution in how we value and hire technical expertise.

A bitter global patent war ends quietly. We dissect how the Amazon-InterDigital pact reveals the hidden costs of innovation and the new rules of tech engagement.

Truist's 63% patent boom is making headlines, but the real story is a strategic fusion of AI and a teammate-driven culture, forging a new model for trust and innovation.

With a fresh $35M, Coram AI is moving security from reactive surveillance to proactive threat hunting. Here's why this shift is redefining a $147B industry.

Binance's spot on the Fortune Crypto 100 is a mainstream win, but it masks a deeper story of regulatory battles and a high-stakes pivot to a financial super app.

Stunning head-to-head trial data shows Takeda's zasocitinib is 2.5x more effective than its rival, signaling a major market disruption and validating a landmark deal.

Dissecting the Med-Metrix acquisition of CanAide. A strategic move by private equity to capture the booming RCM market by tackling provider costs and patient access.

MAIA Biotechnology isn't just opening a new trial site; it's accelerating its assault on a $70B market with a drug showing remarkable early results.

A new routing model promises to solve the persistent liquidity and execution problems plaguing the $31B tokenized asset market. Is this the key?